ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.411,53
0,72%
S&P 500
6.118,71
0,53%
Dow Jones
44.565,07
0,92%
Euro vs US Dollar
1,04657
0,48%
Bitcoin
105.001,74
1,00%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Deutschland
  5. TG

  6. Novo Nordisk (NOV) Börsenkurse

Novo Nordisk

Novo Nordisk (NOV)

Novatti Group Limited
NOV Inc
77,94
0,00
( 0,00% )
Aktualisiert: 07:38:21
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
77,94
Gebot
77,72
Fragen
78,28
Volumen
0,00
0,00 Tagesbereich 0,00
9,6779 52-Wochen-Bereich 139,88
Marktkapitalisierung
350,419B
Handelsende
77,94
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
133.709
Ausgegebene Aktien
4.496.011.436
Dividendenrendite
94.76%
Kurs-Gewinn-Verhältnis
4,46
Gewinn pro Aktie (EPS)
18,61
Erlöse
232,26B
Nettogewinn
83,68B

Über Novo Nordisk

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.novonordisk.com
Hauptsitz
Bagsvaerd, Dnk
Gegründet
-
Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 77,94 €. Over the last year, Novo Nordisk shares have traded in a share price range of 9,6779 € to 139,88 €.

Novo Nordisk currently has 4.496.011.436 shares in issue. The market capitalisation of Novo Nordisk is 350,42 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.46.

NOV Neueste Nachrichten

Weitere Nachrichten

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

20 Januar 2025
UK Regulatory

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence Bagsværd, Denmark, 17 January 2025 – Novo Nordisk...

17 Januar 2025
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 13 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

13 Januar 2025
UK Regulatory

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases Scope of collaboration originally signed in 2023 will significantly expand...

08 Januar 2025
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 20 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

20 Dezember 2024
UK Regulatory

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced...

20 Dezember 2024
UK Regulatory

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed Bagsværd, Denmark, 18 December 2024 — Today...

18 Dezember 2024
UK Regulatory

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

16 Dezember 2024
UK Regulatory

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to...

16 Dezember 2024
UK Regulatory

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close Bagsværd, Denmark...

14 Dezember 2024
UK Regulatory
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-3.049999-3.765895836180.98999981.1973.7223604476.83722557DE
4-8.07-9.3826299267586.0186.629.677899917345680.42391567DE
12-24.48-23.9015817223102.421109.677899913370988.66424736DE
26-45.68-36.9519495227123.62126.329.67789999274297.94368796DE
52-19.55-20.05333880497.49139.889.677899981300107.20346825DE
156-13.76-15.005452562791.7139.889.677899976051104.04062492DE
260-13.76-15.005452562791.7139.889.677899976051104.04062492DE

NOV - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?
The current share price of Novo Nordisk is 77,94 €
How many Novo Nordisk shares are in issue?
Novo Nordisk has 4.496.011.436 shares in issue
What is the market cap of Novo Nordisk?
The market capitalisation of Novo Nordisk is EUR 350,42B
What is the 1 year trading range for Novo Nordisk share price?
Novo Nordisk has traded in the range of 9,6779 € to 139,88 € during the past year
What is the PE ratio of Novo Nordisk?
The price to earnings ratio of Novo Nordisk is 4,46
What is the cash to sales ratio of Novo Nordisk?
The cash to sales ratio of Novo Nordisk is 1,61
What is the reporting currency for Novo Nordisk?
Novo Nordisk reports financial results in DKK
What is the latest annual turnover for Novo Nordisk?
The latest annual turnover of Novo Nordisk is DKK 232,26B
What is the latest annual profit for Novo Nordisk?
The latest annual profit of Novo Nordisk is DKK 83,68B
What is the registered address of Novo Nordisk?
The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880
What is the Novo Nordisk website address?
The website address for Novo Nordisk is www.novonordisk.com
Which industry sector does Novo Nordisk operate in?
Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
W1HOnco Innovations Limited
1,83 €
(26,56%)
45,61k
TGXTalga Group Ltd
0,31 €
(10,32%)
4k
432Arbor Metals Corp
0,39 €
(6,56%)
17,69k
DTCDefence Therapeutics Inc
0,558 €
(6,08%)
500
3CPXiaomi Corporation
4,517 €
(5,51%)
72,25k
G12Global Atomic Corp
0,5615 €
(-10,09%)
7,27k
AOYAlpha and Omega Semiconductor Ltd
34,64 €
(-8,21%)
1,47k
MMOMitsubishi Motors Corporation
2,73 €
(-7,30%)
718
PL6Polaris Inc
50,50 €
(-3,81%)
600
VOSVossloh AG
45,20 €
(-2,69%)
99
3CPXiaomi Corporation
4,517 €
(5,51%)
72,25k
W1HOnco Innovations Limited
1,83 €
(26,56%)
45,61k
M11First Graphene Limited
0,0356 €
(5,33%)
44,38k
432Arbor Metals Corp
0,39 €
(6,56%)
17,69k
IJ8Itm Power
0,4096 €
(1,59%)
17,34k

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten